Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul 21;9(14):e017111.
doi: 10.1161/JAHA.120.017111. Epub 2020 Jun 18.

Perspectives on Cardiopulmonary Critical Care for Patients With COVID-19: From Members of the American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation

Bradley A Maron  1 , Mark T Gladwin  2 , Sebastien Bonnet  3 , Vinicio De Jesus Perez  4 , Sarah M Perman  5 , Paul B Yu  1 , Fumito Ichinose  6
Affiliations

Perspectives on Cardiopulmonary Critical Care for Patients With COVID-19: From Members of the American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation

Bradley A Maron et al. J Am Heart Assoc. .
No abstract available

Keywords: COVID‐19; pulmonary heart disease; shock.

PubMed Disclaimer

Conflict of interest statement

Dr Ichinose is a consultant of Nihon Kohden Innovation Center. Dr Gladwin is a co‐inventor of patents and patent applications directed to the use of recombinant neuroglobin and heme‐based molecules as antidotes for CO poisoning, which have been licensed by Globin Solutions, Inc. Dr Gladwin is also co‐inventor on patents directed to the use of nitrite salts in cardiovascular diseases. Dr Gladwin is a principal‐investigator in a research collaboration with Bayer Pharmaceuticals to evaluate riociguate as a treatment for patients with sickle cell disease. Dr Maron reports being a consultant for Actelion, and co‐inventor on the following patents or patent application that are related to pulmonary hypertension (U.S. Patent #9,605,047; PCT/US2015/029672; Provisional ID: #62475955; Provisional ID: #24624; Provisional ID: #24622). Dr Yu is a co‐founder of Keros Therapeutics, which develops therapeutics for hematological and musculoskeletal diseases which target TGF‐ß signaling pathways. Dr Yu is compensated for work on the company's SAB and owns equity in the publicly traded company. Dr Yu’s interests were reviewed and are managed by Brigham and Women's Hospital and Partners HealthCare in accordance with their conflict of interest policies.

References

    1. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang M, et al. Clinical course and outcomes of critically ill patients with SARS‐CoV‐2 pneumonia in Wuhan, China: a single‐centered, retrospective, observational study. Lancet Respir Med. 2020;8:475–481. - PMC - PubMed
    1. Canelli R, Connor CW, Gonzalez M, Nozari A, Ortega R. Barrier enclosure during endotracheal intubation. N Engl J Med. 2020;382:1957–1958. - PMC - PubMed
    1. Baldi E, Sechi GM, Mare C, Canevari F, Brancaglione A, Primi R, Klersy C, Palo A, Contri E, Ronchi V, et al. Out‐of‐hospital cardiac arrest during the Covid‐19 outbreak in Italy. N Engl J Med. 2020. [Epub ahead of print]. - PMC - PubMed
    1. Edelson DP, Sasson C, Chan PS, Atkins DL, Aziz K, Becker LB, Berg RA, Bradley SM, Brooks SC, Cheng A, et al. Interim guidance for basic and advanced life support in adults, children, and neonates with suspected or confirmed COVID‐19: from the Emergency Cardiovascular Care Committee and Get With the Guidelines®‐Resuscitation Adult and Pediatric Task Forces of the American Heart Association in Collaboration with the American Academy of Pediatrics, American Association for Respiratory Care, American College of Emergency Physicians, The Society of Critical Care Anesthesiologists, and American Society of Anesthesiologists: Supporting Organizations: American Association of Critical Care Nurses and National EMS Physicians. Circulation. 2020. 141:e933‐e943. - PMC - PubMed
    1. Goyal P, Choi JJ, Pinheiro LC, Schenck EJ, Chen R, Jabri A, Satlin MJ, Campion TR Jr, Nahid M, Ringel JB, et al. Clinical characteristics of COVID‐19 in New York City. N Engl J Med. 2020;382:2372–2374. - PMC - PubMed

Publication types

MeSH terms

Substances